SK Biopharmaceuticals wins Red Dot award for 2 devices

Zero Wired and Zero Earbuds detect seizures in epileptics via real-time bio-signal measurement

SK Biopharmaceuticals wins Red Dot award for 2 devices
Yoorim Kim 1
2023-04-12 10:21:16 youforest@hankyung.com
Bio & Pharma

South Korea’s SK Biopharmaceuticals on Tuesday said two of its self-developed wearable devices won the main prize in the health care category of this year’s Red Dot Design Awards. 

Red Dot, one of the world’s top three design awards, received this year around 20,000 entries from 51 countries.

The two items are Zero Wired, a device that connects to a smartphone via a wire, and Zero Earbuds, which measure in real time a user’s complex bio-signals such as brainwaves, electrocardiograms and physical movement.

Both can detect unexpected seizures that occur in people with epilepsy.

Write to Yoorim Kim at youforest@hankyung.com

SK Biopharmaceuticals launches epilepsy drug in France

SK Biopharmaceuticals launches epilepsy drug in France

SK Biopharm's Cenobamate South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company launched the same drug in 15 European countries, beginning with Germany in June this year. The local drug brand name is "On

SK Biopharmaceuticals to make CES debut in January

SK Biopharmaceuticals to make CES debut in January

The researchers of SK Biopharmaceuticals (The courtesy of SK Biopharmaceuticals) SK Biopharmaceuticals will take part in CES 2023, the world's largest trade show for IT and electronics held in Las Vegas, to unveil its medical device for detecting signs of an epileptic seizure.The company will b

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

SK Biopharm researchers South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil’s Eurofarma Laboratórios S.A. to enter the Latin American market.With the technology transfer, SK aims to sell

(* comment hide *}